U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry RACEMIC
Molecular Formula C19H15O4.Na
Molecular Weight 330.3098
Optical Activity ( + / - )
Defined Stereocenters 0 / 1
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of WARFARIN SODIUM

SMILES

[Na+].CC(=O)CC(C1=CC=CC=C1)C2=C([O-])C3=CC=CC=C3OC2=O

InChI

InChIKey=KYITYFHKDODNCQ-UHFFFAOYSA-M
InChI=1S/C19H16O4.Na/c1-12(20)11-15(13-7-3-2-4-8-13)17-18(21)14-9-5-6-10-16(14)23-19(17)22;/h2-10,15,21H,11H2,1H3;/q;+1/p-1

HIDE SMILES / InChI

Approval Year

Unknown
86413
Name Type Language
WARFARIN SODIUM
EP   MART.   ORANGE BOOK   USP   VANDF   WHO-DD   WHO-IP  
Common Name English
WARFARIN SODIUM [USP MONOGRAPH]
Common Name English
WARFARIN SODIUM [VANDF]
Common Name English
SODIUM WARFARIN
Common Name English
WARFARIN SODIUM [ORANGE BOOK]
Common Name English
COUMADIN
Brand Name English
JANTOVEN
Brand Name English
2H-1-BENZOPYRAN-2-ONE, 4-HYDROXY-3-(3-OXO-1-PHENYLBUTYL)-, SODIUM SALT
Common Name English
WARFARIN SODIUM SALT [MI]
Common Name English
Warfarin sodium [WHO-DD]
Common Name English
ZOOCOUMARIN SODIUM SALT
Common Name English
WARFARIN SODIUM [WHO-IP]
Common Name English
WARFARIN SODIUM [MART.]
Common Name English
PROTHROMADIN
Common Name English
ALDOCUMAR
Common Name English
3-(α-Acetonylbenzyl)-4-hydroxycoumarin sodium salt
Common Name English
APO-WARFARIN
Brand Name English
WARFARIN SODIUM SALT
MI  
Common Name English
WARFARIN SODIUM [EP MONOGRAPH]
Common Name English
ATHROMBIN
Brand Name English
WARFARINUM NATRICUM [WHO-IP LATIN]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C45597
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
EPA PESTICIDE CODE 86003
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
NCI_THESAURUS C263
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
Code System Code Type Description
SMS_ID
100000092049
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
CAS
129-06-6
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
ECHA (EC/EINECS)
204-929-4
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
EVMPD
SUB05128MIG
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
ALANWOOD
warfarin-sodium
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
PUBCHEM
16204922
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
NCI_THESAURUS
C1658
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
CHEBI
10034
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
WHO INTERNATIONAL PHARMACOPEIA
WARFARIN SODIUM
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY Description: A white, amorphous or crystalline powder; odourless. Solubility: Soluble in less than 1 part of water and in ethanol (~750 g/l) TS; slightly soluble in ether R. Category: Anticoagulant. Storage: Warfarin sodium should be kept in a well-closed container, protected from light. Labelling: The designation on the container of Warfarin sodium should state whether the substance is in the amorphous or the crystalline, clathrate form. Additional information: Warfarin sodium is discoloured by light. Even in the absence of light, it is gradually degraded on exposureto a humid atmosphere, the decomposition being faster at higher temperatures.Definition: Warfarin sodium contains not less than 98.0% and not more than 102.0% of C19H15NaO4, calculated with reference to the anhydrous and 2-propanol-free substance.
ChEMBL
CHEMBL1464
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
DAILYMED
6153CWM0CL
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
MERCK INDEX
m11506
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY Merck Index
EPA CompTox
DTXSID7035010
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
DRUG BANK
DBSALT000278
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
FDA UNII
6153CWM0CL
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY
RXCUI
114194
Created by admin on Fri Dec 15 15:06:25 UTC 2023 , Edited by admin on Fri Dec 15 15:06:25 UTC 2023
PRIMARY RxNorm
ACTIVE MOIETY
Structure of WARFARIN
SUBSTANCE RECORD
Structure of WARFARIN SODIUM
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966